Clinical significance of FGF-23 in Chronic Kidney Disease Patients

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2015, Vol 3, Issue 2

Abstract

Fibroblast growth factor 23 (FGF-23) is a potent regulator of serum phosphate level. In CKD, circulating FGF-23 levels gradually increase with declining renal function. Higher FGF-23 level was associated with higher atherosclerosis score. We aimed to study the correlation between FGF-23 and the parameters that have effects on morbidity and mortality in CKD patients and to establish its role as biomarker of cardiovascular disease risk in these patients. This study comprises 80 subjects divided into three groups: group I (40 patients with CKD on regular HD), group II (20 patients with CKD on conservative treatment) group 3 (20 healthy subjects as a control). All patients and controls were subjected to the following: echocardiography, carotid duplex and laboratory investigations including serum calcium, phosphate, parathyroid hormone, alkaline phosphatase, creatinine, blood urea, Iron profile (serum iron, serum ferritin, Tsat, TIBC, FGF23. The laboratory data showed significant increase in creatinine, urea, phosphorus, CaPh product, PTH and FGF-23 with significant decrease in serum calcium and ferritin in group 1 & 2 compared to the controls. There were a statistically significant increase in IVST, PWT, LVM, LVMI and CIMT in group 1 & 2 compared to the controls. FGF-23 showed a positive correlation with creatinine, urea, PTH, CaPh, LVMI & CIMT and negative correlation with ferritin, Hb & HCT. We concluded that elevated FGF-23 level was independently associated with faster progression of CKD, therapy-resistant secondary hyperparathyroidism and increased cardiovascular risk in CKD patients and so, could represent a promising therapeutic target that might improve the fatal prognosis of patients with CKD. Keywords: CKD, Hemodialysis, FGF-23, PTH, LVM, CIMT.

Authors and Affiliations

Manar Raafat, Mona Madkour, Amna Metwaly, Fatma Mohammad Nasr, Osama Mosbah, Noha El-Sheikh

Keywords

Related Articles

Use of Pleural Fluid Lymphocyte Neutrophil Ratio in Addition to Pleural Fluid Adenosine Deaminase for the Diagnosis of Tuberculous Pleural Effusion

Increased pleural fluid adenosine deaminase (ADA) activity is classically associated with tuberculous pleuritis. However, increased activity can also occur in a number of other diseases and this may negatively affect dia...

Effect of Different Nerve Block of Local Anesthetics with Epinephrine on Selected Cardiovascular Parameters

Abstract: Lignocaine can also be used for nerve blocks. Lidocaine, also known as xylocaine or lignocaine is a medication used to numb tissue in a specific area and to treat ventricular tachycardia. Sixty subjects (15 fem...

Cervical Ganglioneuroblastoma (About a Rare Case)

Neuroblastic tumors are the third leading cause of tumors in young children after leukemia and central nervous system tumors. These tumors are classified into three histological groups: neuroblastoma, ganglioneuroblastom...

Epidemiological Data on the Drugs Use from Youngsters in Shkoder City

Abstract: Drugs use is a phenomenon already present in our schools, constituting a problem which is related not only to health but economic and social aspects as well. The aim of this study is to provide epidemiological...

Plasma Total Antioxidant Activity and Its Relation with Serum Uric Acid in Type 2 Diabetes and Non Diabetes: A Comparative Study

Oxidative stress has been found to be associated with variety of diseases including diabetes. It is conceivable that alteration in plasma antioxidant reserve along with serum uric acid levels may have a crucial role in d...

Download PDF file
  • EP ID EP372931
  • DOI -
  • Views 70
  • Downloads 0

How To Cite

Manar Raafat, Mona Madkour, Amna Metwaly, Fatma Mohammad Nasr, Osama Mosbah, Noha El-Sheikh (2015). Clinical significance of FGF-23 in Chronic Kidney Disease Patients. Scholars Journal of Applied Medical Sciences, 3(2), 741-750. https://europub.co.uk/articles/-A-372931